{"issuance_frequency":"","notes_translated":{"fr":"Le Relevé des maladies transmissibles au Canada est une publication bilingue et libre d'accès revue par un comité de lecture portant sur la prévention et le contrôle des maladies infectieuses nouvelles et tenaces.","en":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. "},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"unknown","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","metadata_created":"2018-12-27T18:40:58.712407","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2020-09-25T15:35:17.614056","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2018-12-27","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Pratiques de prescription","Médecins de soins de santé primaires","Canada","Traitement","Gonorrhée","Données probantes","Utilisation optimale des intervalles de dépistage du VIH","Personnes séronégatives","Groupes à risque","Protocole d’examen systématique","Taux d’incidence mobile","Surveiller la coqueluche","Utilisation d’une dose fractionnée de vaccin","Fièvre jaune","Pénurie de vaccin","Prévention","Traitement","Virus Zika","Professionnels de la santé","Bandes dessinées animées","Sensibilisation aux infections transmissibles sexuellement","ITS","Recommandations"],"en":["Canadian","Primary care physicians","Prescribing","Treatment","Gonorrhea","Evidence","Optimal HIV testing intervals","HIV-negative","Individuals","Risk groups","Systematic review protocol","Rolling incidence","Monitor pertussis","Fractional dose vaccine","Yellow fever","Vaccine shortage","Prevention","Treatment","Zika virus","Canadian Health Care professionals","Motion comics","Sexually Transmitted Infections","STI education","Recommendations"]},"relationships_as_object":[],"creator_user_id":"4cfa9a9c-1d95-40eb-86f9-bc0c8ec45d1f","title_translated":{"fr":"RMTC : Volume 43-2, le 2 février 2017 : Maladies transmissibles sexuellement","en":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"c5ea2b3f-5e96-4f30-862c-bb183a527d5d","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-2, le 2 février 2017 : Maladies transmissibles sexuellement","en":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections","language":["en"],"created":"2018-12-27T18:40:59.738881","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-2-february-2-2017.html","last_modified":null,"position":0,"revision_id":"c13b2d6c-314e-4916-8cda-23522feb024f","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"33e4ece4-5ecd-42de-a6c5-91b84c857655","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-2, le 2 février 2017 : Maladies transmissibles sexuellement","en":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections","language":["fr"],"created":"2018-12-27T18:40:59.738890","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-2-2-fevrier-2017.html","last_modified":null,"position":1,"revision_id":"4e5931a2-e676-4f36-b62b-39b05521a640","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"id":"ee715892-bfdd-4563-9540-f889db11f043","state":"active","name_translated":{"fr":"RMTC : Volume 43-2, le 2 février 2017 : Maladies transmissibles sexuellement","en":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections","language":["en"],"created":"2018-12-27T18:40:59.738892","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/17vol43/dr-rm43-2/assets/pdf/17vol43_2-eng.pdf","last_modified":null,"position":2,"revision_id":"7eea9e7f-778e-4edc-b1b2-519f4bd645bf","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"4d7d2a9b-eca4-49db-813f-6f0248e68e71","related_relationship":"","name_translated":{"fr":"RMTC : Volume 43-2, le 2 février 2017 : Maladies transmissibles sexuellement","en":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections"},"hash":"","description":"","format":"PDF","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections","language":["fr"],"created":"2018-12-27T18:40:59.738895","url":"https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/17vol43/dr-rm43-2/assets/pdf/17vol43_2-fra.pdf","last_modified":null,"position":3,"revision_id":"b7f56312-3df3-4a44-b499-9fb4c71be1e4","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"b1468293-02f2-423b-aed9-3aade7ed7c7a","related_relationship":"","name_translated":{"fr":"Quelles sont les pratiques de prescription des médecins de soins de santé primaires au Canada pour le traitement de la gonorrhée?","en":"What are Canadian primary care physicians prescribing for the treatment of gonorrhea?"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"What are Canadian primary care physicians prescribing for the treatment of gonorrhea?","language":["en"],"created":"2018-12-27T18:40:59.738897","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-2-february-2-2017/ccdr-volume-43-2-february-2-2017-sexually-transmitted-infections.html","last_modified":null,"position":4,"revision_id":"a63ead1d-0e73-4889-a0b4-f5175bf80afc","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"b698087e-10d1-4f95-8480-b322feec819d","related_relationship":"","name_translated":{"fr":"Quelles sont les pratiques de prescription des médecins de soins de santé primaires au Canada pour le traitement de la gonorrhée?","en":"What are Canadian primary care physicians prescribing for the treatment of gonorrhea?"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"What are Canadian primary care physicians prescribing for the treatment of gonorrhea?","language":["fr"],"created":"2018-12-27T18:40:59.738899","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-2-2-fevrier-2017/rmtc-volume-43-2-2-fevrier-2017-maladies-transmissibles-sexuellement.html","last_modified":null,"position":5,"revision_id":"14e6a77c-4f76-490f-b8c5-01f2e84ea42e","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"1e6256f0-4f47-470b-9640-105ef7412a07","related_relationship":"","name_translated":{"fr":"Données probantes en matière d'utilisation optimale des intervalles de dépistage du VIH chez les personnes séronégatives provenant de divers groupes à risque : un protocole d'examen systématique","en":"Evidence for optimal HIV testing intervals in HIV-negativeindividuals from various risk groups: a systematic review protocol"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evidence for optimal HIV testing intervals in HIV-negativeindividuals from various risk groups: a systematic review protocol","language":["en"],"created":"2018-12-27T18:40:59.738901","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-2-february-2-2017/ccdr-volume-43-2-february-2-2017-sexually-transmitted-infections-1.html","last_modified":null,"position":6,"revision_id":"8374fb8b-bdb7-4214-a91f-6118b3d7046c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"01689968-8347-4897-8108-180d9decf136","related_relationship":"","name_translated":{"fr":"Données probantes en matière d'utilisation optimale des intervalles de dépistage du VIH chez les personnes séronégatives provenant de divers groupes à risque : un protocole d'examen systématique","en":"Evidence for optimal HIV testing intervals in HIV-negativeindividuals from various risk groups: a systematic review protocol"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Evidence for optimal HIV testing intervals in HIV-negativeindividuals from various risk groups: a systematic review protocol","language":["fr"],"created":"2018-12-27T18:40:59.738903","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-2-2-fevrier-2017/rmtc-volume-43-2-2-fevrier-2017-maladies-transmissibles-sexuellement-1.html","last_modified":null,"position":7,"revision_id":"e934e3dd-35fe-4a08-9748-530df3005f22","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"d097c9b8-abdd-41fc-84ae-6642e5016644","related_relationship":"","name_translated":{"fr":"Utilisation d'un taux d'incidence mobile sur 40 jours pour surveiller la coqueluche en Nouvelle-Écosse en 2015","en":"Use of a 40-day rolling incidence to monitor pertussis in Nova Scotia, 2015"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Use of a 40-day rolling incidence to monitor pertussis in Nova Scotia, 2015","language":["en"],"created":"2018-12-27T18:40:59.738906","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-2-february-2-2017/ccdr-volume-43-2-february-2-2017-sexually-transmitted-infections-2.html","last_modified":null,"position":8,"revision_id":"c92ca9e3-e849-4fdb-a24e-45306efae14c","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"35d7903b-44ef-4174-ae50-7e1b0e70e546","related_relationship":"","name_translated":{"fr":"Utilisation d'un taux d'incidence mobile sur 40 jours pour surveiller la coqueluche en Nouvelle-Écosse en 2015","en":"Use of a 40-day rolling incidence to monitor pertussis in Nova Scotia, 2015"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Use of a 40-day rolling incidence to monitor pertussis in Nova Scotia, 2015","language":["fr"],"created":"2018-12-27T18:40:59.738908","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-2-2-fevrier-2017/rmtc-volume-43-2-2-fevrier-2017-maladies-transmissibles-sexuellement-2.html","last_modified":null,"position":9,"revision_id":"c0ea4b7d-f5a0-4c7c-9495-69f19aaa2a10","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"1a41b383-ca50-4a51-b69d-8a622ed60768","related_relationship":"","name_translated":{"fr":"Enquête de 2016 auprès des lecteurs du Relevé des maladies transmissibles au Canada","en":"Canada Communicable Disease Report 2016 readership survey"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canada Communicable Disease Report 2016 readership survey","language":["en"],"created":"2018-12-27T18:40:59.738910","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-2-february-2-2017/ccdr-volume-43-2-february-2-2017-sexually-transmitted-infections-3.html","last_modified":null,"position":10,"revision_id":"6df76e05-4cb8-4a5d-a6e0-7cb6e8cbccab","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"101a8e23-662f-4f3b-b132-cbbcbe8af087","related_relationship":"","name_translated":{"fr":"Enquête de 2016 auprès des lecteurs du Relevé des maladies transmissibles au Canada","en":"Canada Communicable Disease Report 2016 readership survey"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Canada Communicable Disease Report 2016 readership survey","language":["fr"],"created":"2018-12-27T18:40:59.738912","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-2-2-fevrier-2017/rmtc-volume-43-2-2-fevrier-2017-maladies-transmissibles-sexuellement-3.html","last_modified":null,"position":11,"revision_id":"681e6856-f781-4ad6-bf53-54acc7d8a428","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"2c45d6c0-e340-4a52-9774-ea5a599def20","related_relationship":"","name_translated":{"fr":"Recommandations canadiennes provisoires concernant l’utilisation d’une dose fractionnée du vaccin contre la fièvre jaune durant une pénurie du vaccin – maintenant en vigueur","en":"Interim Canadian Recommendations for the use of fractional dose of yellow fever vaccine during a vaccine shortage: Now in effect"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Interim Canadian Recommendations for the use of fractional dose of yellow fever vaccine during a vaccine shortage: Now in effect","language":["en"],"created":"2018-12-27T18:40:59.738914","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-2-february-2-2017/ccdr-volume-43-2-february-2-2017-sexually-transmitted-infections-4.html","last_modified":null,"position":12,"revision_id":"806988bf-fce0-4a3b-99f8-fb3be6d88b26","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"5f790961-1def-42d2-8fb3-840ee9f99246","related_relationship":"","name_translated":{"fr":"Recommandations canadiennes provisoires concernant l’utilisation d’une dose fractionnée du vaccin contre la fièvre jaune durant une pénurie du vaccin – maintenant en vigueur","en":"Interim Canadian Recommendations for the use of fractional dose of yellow fever vaccine during a vaccine shortage: Now in effect"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Interim Canadian Recommendations for the use of fractional dose of yellow fever vaccine during a vaccine shortage: Now in effect","language":["fr"],"created":"2018-12-27T18:40:59.738917","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-2-2-fevrier-2017/rmtc-volume-43-2-2-fevrier-2017-maladies-transmissibles-sexuellement-4.html","last_modified":null,"position":13,"revision_id":"7b789ba0-5c71-49b6-8ee7-69aaa9d6a0af","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"417fbae9-72f2-4653-bdee-d145d7e8c19e","related_relationship":"","name_translated":{"fr":"Recommandations pour la prévention et le traitement du virus Zika à l’intention des professionnels de la santé : troisième mise à jour","en":"Recommendations on the prevention and treatment of Zika virus for Canadian health care professionals: 3rd Update"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Recommendations on the prevention and treatment of Zika virus for Canadian health care professionals: 3rd Update","language":["en"],"created":"2018-12-27T18:40:59.738919","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-2-february-2-2017/ccdr-volume-43-2-february-2-2017-sexually-transmitted-infections-5.html#a1","last_modified":null,"position":14,"revision_id":"56e511ad-a9e1-4ddd-a8cc-e6f7a5de6507","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"db961258-64cc-4f4f-b82c-10677b684794","related_relationship":"","name_translated":{"fr":"Recommandations pour la prévention et le traitement du virus Zika à l’intention des professionnels de la santé : troisième mise à jour","en":"Recommendations on the prevention and treatment of Zika virus for Canadian health care professionals: 3rd Update"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Recommendations on the prevention and treatment of Zika virus for Canadian health care professionals: 3rd Update","language":["fr"],"created":"2018-12-27T18:40:59.738921","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-2-2-fevrier-2017/rmtc-volume-43-2-2-fevrier-2017-maladies-transmissibles-sexuellement-5.html#a1","last_modified":null,"position":15,"revision_id":"1e3064a7-beb6-47cf-adb4-53edf9270bff","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"38673620-00ba-49c2-9633-9cc712441d30","related_relationship":"","name_translated":{"fr":"Utilisation de bandes dessinées animées pour la sensibilisation aux infections transmissibles sexuellement (ITS)","en":"Use of motion comics for STI education"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Use of motion comics for STI education","language":["en"],"created":"2018-12-27T18:40:59.738924","url":"https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2017-43/ccdr-volume-43-2-february-2-2017/ccdr-volume-43-2-february-2-2017-sexually-transmitted-infections-5.html#a2","last_modified":null,"position":16,"revision_id":"c35eba02-8e59-4b18-bfac-ed26d1754b37","resource_type":"website"},{"cache_last_updated":null,"unique_identifier":"","package_id":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","datastore_active":false,"character_set":"","size":0,"related_type":"","state":"active","id":"d45d6259-c6b8-4461-93f3-62e5cb72d4b4","related_relationship":"","name_translated":{"fr":"Utilisation de bandes dessinées animées pour la sensibilisation aux infections transmissibles sexuellement (ITS)","en":"Use of motion comics for STI education"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Use of motion comics for STI education","language":["fr"],"created":"2018-12-27T18:40:59.738926","url":"https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2017-43/rmtc-volume-43-2-2-fevrier-2017/rmtc-volume-43-2-2-fevrier-2017-maladies-transmissibles-sexuellement-5.html#a2","last_modified":null,"position":17,"revision_id":"ff1bfc6a-e367-4bd4-88ca-18a1320d87a5","resource_type":"website"}],"place_of_publication":[],"num_resources":18,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Agence de la santé publique du Canada","en":"Public Health Agency of Canada"},"date_published":"2017-02-02 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:57.068700","title":"Public Health Agency of Canada | Agence de la santé publique du Canada","name":"phac-aspc","is_organization":true,"state":"active","image_url":"","revision_id":"96161da6-edc7-4d1d-99e0-baac9df7b3b9","type":"organization","id":"1C71053B-AA64-4646-956B-41631C396018","approval_status":"approved"},"name":"05cc6e44-f32f-4782-835e-7c9fd22e90f0","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. ","owner_org":"1C71053B-AA64-4646-956B-41631C396018","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"CCDR: Volume 43-2, February 2, 2017: Sexually transmitted infections","revision_id":"def45256-2a54-4720-80f7-ea351a7b6dea"}